L-Nutra vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
L-Nutra created the patented ProLon Fasting Mimicking Diet, backed by 25+ years of USC longevity research and 37 clinical studies; a 2024 Nature Communications study showed 2.5-year biological age reduction after 3 cycles.
About
L-Nutra is a nutri-technology company pioneering nutrition for longevity through evidence-based dietary programs and plant-based therapies. Founded by Dr. Valter Longo — director of the USC Longevity Institute and one of the world''s leading longevity scientists — L-Nutra commercializes decades of academic research into practical consumer and clinical nutrition products. Its flagship product, ProLon, is the world''s first patented Fasting Mimicking Diet (FMD): a 5-day proprietary nutrition program that provides carefully calibrated calories and macronutrients to trigger the cellular rejuvenation and metabolic benefits of fasting while allowing food consumption. ProLon is backed by 25+ years of scientific research, tested across 37 clinical studies, and protected by 134 global patents.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies;
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.